BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9108675)

  • 1. Polycystic kidney disease: huge kidneys, huge problems, huge progress.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 1997; 108():165-70; discussion 170-2. PubMed ID: 9108675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
    Sessa A; Ghiggeri GM; Turco AE
    J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of progression in autosomal dominant polycystic kidney disease.
    Grantham JJ
    Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.
    Wilson PD; Du J; Norman JT
    Eur J Cell Biol; 1993 Jun; 61(1):131-8. PubMed ID: 8223698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and loss of renal tissue in polycystic kidney diseases.
    Woo D
    N Engl J Med; 1995 Jul; 333(1):18-25. PubMed ID: 7776989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease.
    Grantham JJ; Schreiner GF; Rome L; Grenz L; Joly A
    Proc Assoc Am Physicians; 1997 Jul; 109(4):397-408. PubMed ID: 9220537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
    Lebeau C; Hanaoka K; Moore-Hoon ML; Guggino WB; Beauwens R; Devuyst O
    Pflugers Arch; 2002 Sep; 444(6):722-31. PubMed ID: 12355171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
    Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
    Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case for water in the treatment of polycystic kidney disease.
    Torres VE; Bankir L; Grantham JJ
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1140-50. PubMed ID: 19443627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
    Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures.
    Elberg G; Guruswamy S; Logan CJ; Chen L; Turman MA
    Cell Tissue Res; 2008 Feb; 331(2):495-508. PubMed ID: 18004594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
    Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
    J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to inhibit cyst formation in ADPKD.
    Calvet JP
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1205-11. PubMed ID: 18434615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease.
    Ye M; Grantham JJ
    N Engl J Med; 1993 Jul; 329(5):310-3. PubMed ID: 8321258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.